# Re-treatment of HCV Following DAA Failure

> **NCT03483987** · NA · TERMINATED · sponsor: **Sanjay Gandhi Postgraduate Institute of Medical Sciences** · enrollment: 18 (actual)

## Conditions studied

- Chronic Hepatitis C

## Interventions

- **DRUG:** Sof+Ledi+R arm
- **DRUG:** Sof+Ledi+R+Peg-IFN arm
- **DRUG:** Sof+Dacla+R arm
- **DRUG:** Sof+Dacla+R+Peg-IFN arm
- **DRUG:** Sof+Velpa+R arm
- **DRUG:** Sof+Velpa+R+Peg-IFN arm

## Key facts

- **NCT ID:** NCT03483987
- **Lead sponsor:** Sanjay Gandhi Postgraduate Institute of Medical Sciences
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-02-10
- **Primary completion:** 2022-04-30
- **Final completion:** 2022-04-30
- **Target enrollment:** 18 (ACTUAL)
- **Why stopped:** Difficulty in recruiting the participants
- **Last updated:** 2022-05-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03483987

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03483987, "Re-treatment of HCV Following DAA Failure". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03483987. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*